Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred - PubMed (original) (raw)

Catherine M Roe, Andrés Villegas, Gabriel Bedoya, Sumi Chakraverty, Gloria García, Victoria Tirado, Joanne Norton, Silvia Ríos, Maribel Martínez, Kenneth S Kosik, Francisco Lopera, Alison M Goate

Affiliations

Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred

Pau Pastor et al. Ann Neurol. 2003 Aug.

Abstract

We previously have identified a large kindred from Colombia in which Alzheimer's disease (AD) is caused by the E280A presenilin 1 (PS1) mutation. The objective of this study was to examine whether environmental and genetic factors are responsible for variation in the phenotypic expression of the E280A PS1 mutation. We genotyped coding and promoter polymorphisms of the APOE gene in carriers of the E280A PS1 mutation. Kaplan-Meier product-limit and Cox proportional hazard models were used in the statistical analyses. DNA was available from 114 carriers of the E280A PS1 mutation, including 52 subjects with AD. APOE epsilon 4 allele carriers were more likely to develop AD at an earlier age than subjects without the epsilon 4 allele (hazard ratio, 2.07; 95% confidence interval, 1.07-3.99; p = 0.030). Subjects with low education were more likely to develop AD later than those with higher education (hazard ratio, 0.476; 95% confidence interval, 0.26-0.87). Low educational level was associated with rural residence (p < 0.001). Promoter APOE variants did not influence either the onset or the duration of the disease. This study is the first to our knowledge to demonstrate that genetic and environmental factors influence age of onset in a kindred with a familial AD mutation.

Ann Neurol 2003

PubMed Disclaimer

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources